Characteristics and outcomes of newly diagnosed acute myeloid leukemia patients receiving venetoclax combinations vs other therapies: Results from the AML real world evidence (ARC) Initiative Meeting Abstract
| Authors: | Pollyea, D. A.; Stahl, M.; Talati, C.; Asghari, H.; Lai, C.; Abedin, S.; Zeidner, J. F.; Muluneh, B.; Xavier, M.; Edwards, W.; Wolach, O.; Moshe, Y.; Lavie, D.; Zuckerman, T.; Choi, M.; Bui, C. N.; Svensson, A. E.; Kye, S.; Burne, R.; Guerin, A.; Ma, E.; Montez, M.; Goldberg, A. D. |
| Abstract Title: | Characteristics and outcomes of newly diagnosed acute myeloid leukemia patients receiving venetoclax combinations vs other therapies: Results from the AML real world evidence (ARC) Initiative |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607547206212 |
| DOI: | 10.1182/blood-2020-134789 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 26 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
